BMRN vs. ILMN: Which Stock Is the Better Value Option?
What Makes Illumina (ILMN) a New Strong Buy Stock
Here's How Much $1000 Invested In Illumina 20 Years Ago Would Be Worth Today
Illumina (ILMN) Rose on Strong Clinical Momentum
Illumina (ILMN) Q2 2026 Earnings Call Transcript
Canaccord Genuity Maintains Hold on Illumina, Raises Price Target to $205
Citigroup Maintains Sell on Illumina, Raises Price Target to $113
Illumina, Inc. (ILMN) Hits Fresh High: Is There Still Room to Run?
Piper Sandler Reiterates Overweight on Illumina, Raises Price Target to $225
Why Illumina (ILMN) Is Up 5.7% After Raising 2026 Revenue Outlook On Clinical Sequencing
Can Illumina (ILMN) Hold Its Price As Cash Flow And Earnings Clash?
Illumina (ILMN) Could Be 19% Overvalued Following Its Q2 Beat And Guidance Raise
Illumina Q2 Earnings Call Highlights
ILMN Q2 Deep Dive: Clinical Strength, Platform Expansion, and Strategic Focus Drive Guidance Lift
Illumina CEO on Genomic Sequencing Opportunities and AI
RBC Capital Maintains Outperform on Illumina, Raises Price Target to $230
Illumina, Inc. 2026 Q2 - Results - Earnings Call Presentation
JP Morgan Maintains Overweight on Illumina, Raises Price Target to $230
TD Cowen Maintains Hold on Illumina, Raises Price Target to $210
Illumina, Inc. Q2 2026 Earnings Call Summary
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.